Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation

FEBS Lett. 1989 Jul 17;251(1-2):187-90. doi: 10.1016/0014-5793(89)81452-8.

Abstract

Previously we have found that elongation factor 2 (EF-2) from mammalian cells can be phosphorylated by a special Ca2+/calmodulin-dependent protein kinase (EF-2 kinase). Phosphorylation results in complete inactivation of EF-2 in the poly(U)-directed cell-free translation system. However, the partial function of EF-2 affected by phosphorylation remained unknown. Here we show that phosphorylated EF-2, unlike non-phosphorylated EF-2, is unable to switch ribosomes carrying poly(U) and Phe-tRNA in the A site to a puromycin-reactive state. Thus, phosphorylation of EF-2 seems to block its ability to promote a shift of the aminoacyl(peptidyl)-tRNA from the A site to the P site, i.e. translocation itself.

MeSH terms

  • Animals
  • Calcium / pharmacology*
  • Calmodulin / pharmacology*
  • Guanosine Triphosphate / analogs & derivatives
  • Guanosine Triphosphate / pharmacology
  • Guanylyl Imidodiphosphate / pharmacology
  • Peptide Elongation Factor 2
  • Peptide Elongation Factors / metabolism*
  • Phosphorylation
  • Poly U / metabolism
  • Protein Kinases / metabolism*
  • Puromycin / metabolism
  • RNA, Transfer, Phe / metabolism
  • Rabbits
  • Ribosomes / metabolism
  • Structure-Activity Relationship

Substances

  • Calmodulin
  • Peptide Elongation Factor 2
  • Peptide Elongation Factors
  • RNA, Transfer, Phe
  • Poly U
  • guanosine 5'-(beta,gamma-methylene)triphosphate
  • Guanylyl Imidodiphosphate
  • Puromycin
  • Guanosine Triphosphate
  • Protein Kinases
  • Calcium